Make Informed Investment Decisions with Affordable Access to Experts
A Community Doctor's Perspective on Sickle Cell Disease & Voxelotor's Potential (GBT440)Ticker(s): GBT
Name: Dr Mamta Vijayvargiya - MD
- Hematologist at Osceola Cancer Center in FL and in private practice.
- Currently manages 25 patients with sickle cell and attended ASH 2019.
- Board certified in both medical oncology and hematology; member of the American Society of Clinical Oncology, the American Society of Hematology and the American College of physicians.
Please describe your clinical practice; how many patients with sickle cell disease do you currently manage?Added By: c_admin
What % of your patients would be good candidates for voxeletor?Added By: c_admin
What is your perspective with regard to patient compliance? What have you seen by way of compliance with the current standard of care?
Do you view the recently approved Novartis compound as complementary or competitive with voxeletor?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.